Valuation
26% of the score, 33% here after data gaps
95median 53
Nurix Therapeutics, Inc. is valued at 9.6x its operating profit, including debt: a low multiple.
60x
50x
35x
25x
18x
12x
8x
9.6x
Full points at 8x or less, none from 60xfull points
NRIXNurix Therapeutics, Inc.
$25.33+152% 1Y
$25.33
$9.8452 weeks$27.79
RyuScore
Seven criteria, each scored 0 to 100 on a published scale, weighted into one number.
RyuScore 43 out of 100, Below average
Below average. Nurix Therapeutics, Inc. scores higher than 38% of the 2,231 companies Ryufin scores.
Carried by valuation and earnings quality, held back by return on capital and return on new capital.
Healthcare median 19 · all companies 55
How the score has moved
At each fiscal year end, from the reports and price of the time6
8
6
12
43
2022202320242025today
The biggest move was up 31 points from 2025 to today, mostly valuation.
Return on capital
18% of the score, 23% here after data gaps
0median 24
Over 6 years the business earned -95% a year after tax on the capital it uses.
2%
8%
15%
25%
-95%
None at 2% or less, full points from 25%full points
6 years agolatest -70%
Return on new capital
16% of the score, 20% here after data gaps
0median 33
No operating profit over the period, so nothing was earned to reinvest.
Capital allocation
14% of the score, 18% here after data gaps
40median 63
How management spends the money: shares bought back or issued, and whether assets grow faster than the business they serve.
Share countUp 19.2% a year over 4 years: new shares
05%
-3%
19%
0 pointsfull points
Assets against salesAssets grew 12% a year, sales 36%
10012%
-2%
-25%
0 pointsfull points
Cycle position
Taken out: its 12% is shared by the others
n/ano data
Margins have been too thin to measure a cycle against.
Balance sheet
Taken out: its 8% is shared by the others
n/ano data
No debt or interest figures on file.
Earnings quality
6% of the score, 8% here after data gaps
71median 90
Whether the reported profit arrives as cash, and whether the accounts show the usual signs of stretching.
AccrualsCash ran ahead of profit by 2.2% of assets
718%
0%
-8%
-2.2%
0 pointsfull points
How the RyuScore works
Each criterion earns 0 to 100 points on the scale drawn under it, and the RyuScore is their average weighted 26, 18, 16, 14, 12, 8 and 6. Scales bend in the company's favour between their ends, so an ordinary figure is never already near zero. For NRIX, cycle position and balance sheet could not be measured from the filings, so they are taken out and the remaining weights scale up.
Built from the company's annual and quarterly filings with the SEC and today's share price. Banks, insurers and property trusts are not scored: their debt is their raw material, so these yardsticks mean something else there. Figures as of 2026-08-31, latest annual report FY2025.